Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-25-016871
Filing Date
2025-05-14
Accepted
2025-05-14 16:41:26
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 cont20250506_s3.htm S-3 519346
2 EXHIBIT 1.2 ex_815361.htm EX-1.2 268708
3 EXHIBIT 4.5 ex_815362.htm EX-4.5 532861
4 EXHIBIT 5.1 ex_815367.htm EX-5.1 25612
5 EXHIBIT 5.2 ex_817329.htm EX-5.2 7796
6 EXHIBIT 23.1 ex_815368.htm EX-23.1 2170
7 EXHIBIT FILING FEES ex_815370.htm EX-FILING FEES 39578
8 a01.jpg GRAPHIC 12975
9 gundersonimage.jpg GRAPHIC 71541
  Complete submission text file 0001437749-25-016871.txt   1513822
Mailing Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Filer) CIK: 0001855175 (see all company filings)

EIN.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-287275 | Film No.: 25946541
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)